Relationship between obesity, related comorbidities, and neuroinflammation in young and older adults

Poster No:

2628 

Submission Type:

Abstract Submission 

Authors:

Filip Morys1, Max Tweedale1, Christina Tremblay1, Alexandre Pastor-Bernier1, Houman Azizi1, Alain Dagher1

Institutions:

1Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec

First Author:

Filip Morys  
Montreal Neurological Institute and Hospital, McGill University
Montreal, Quebec

Co-Author(s):

Max Tweedale  
Montreal Neurological Institute and Hospital, McGill University
Montreal, Quebec
Christina Tremblay  
Montreal Neurological Institute and Hospital, McGill University
Montreal, Quebec
Alexandre Pastor-Bernier  
Montreal Neurological Institute and Hospital, McGill University
Montreal, Quebec
Houman Azizi  
Montreal Neurological Institute and Hospital, McGill University
Montreal, Quebec
Alain Dagher  
Montreal Neurological Institute and Hospital, McGill University
Montreal, Quebec

Introduction:

Obesity causes persistent, low-grade systemic metabolic inflammation [1]. Studies describe negative effects of such inflammation and other obesity-related factors on the brain [1]. Recently, studies also suggest that brain derangements might constitute a risk factor for excess weight gain [2–4]. For example, inflammation in the hypothalamus - initiated by a plethora of factors, e.g. genetics, overnutrition or high-fat diets - can often precede the onset of obesity and lead to altered homeostatic food-intake processes [5, 6]. Such phenomena can lead to a vicious cycle of food intake, whereby overnutrition leads to changes in the brain, which can further lead to overnutrition, obesity, thus increasing brain damage. Inflammation caused by obesity and related metabolic derangements would not only be visible in the hypothalamus, but also in other vulnerable brain areas. At the same time, only hypothalamic inflammation would lead to altered food intake. Here, we looked at diffusion weighted imaging data from magnetic resonance (MR DWI) to assess inflammation in several subcortical brain structures in two large-scale cohorts of different ages. We investigated the relationship of the inflammation measures with obesity and related comorbidities to explore mechanisms linking excess weight with neuroinflammation.

Methods:

We used data from the UK Biobank (UKB; n=26,242; mean age=63 years; body mass index, BMI=26.15 kg/m^2; 13,801 women) and Human Connectome Project (HCP, n=819; age=29 years; BMI=26.50 kg/m^2; 428 women) samples of healthy participants with no neurological disorders [7, 8]. We processed DWI data using Tractoflow to derive diffusion tensor imaging (DTI) measures of fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD), which could reflect neuroinflammation in grey matter structures [3, 9]. We investigated the hypothalamus, caudate nucleus, putamen, pallidum, nucleus accumbens, and hippocampus as regions of interest. Using linear regression we related the DTI measures to measures of adiposity (BMI) and other comorbidities (hypertension, c-reactive protein reflecting systemic inflammation (only UKB), blood glycated haemoglobin levels (HbA1c), blood glucose levels (only UKB), and blood lipid levels (only UKB)). Results were corrected for multiple comparisons using false discovery rate correction.

Results:

In the HCP sample of young adults, we only found significant negative associations between DTI measures and BMI, predominantly for hippocampus and pallidum, but no associations between DTI measures and SBP, DBP, or HbA1c (Fig. 1). In the older UKB sample, we found consistently positive associations between FA and most investigated obesity-related measures in all brain structures except the caudate nucleus, where the association was opposite (Fig. 2). Other diffusivity measures had weaker and negative associations with investigated variables in most structures, except for the caudate nucleus.
Supporting Image: Fig1.png
Supporting Image: Fig2.png
 

Conclusions:

DTI measures were weakly associated with obesity-related measures in the investigated subcortical structures in the young, healthy sample. Some associations, for example positive relationship between DTI measures and BMI in the hippocampus or pallidum, might suggest an ongoing process of neuroinflammation, however, these effects seem to be small and not present in all the tested brain structures. Conversely, we observed significant associations between obesity-related measures and DTI measures in most of the subcortical structures in the older sample. Positive associations with FA might indicate a process of gliosis that restricts water diffusion in grey matter through increases in cellularity [3]. Because this process seems to be ongoing in multiple subcortical structures not directly related to food intake, it seems that it is an effect, rather than a cause, of obesity and related comorbidities. In sum, we are showing that obesity could be related to neuroinflammation and thus leads to neurodegeneration.

Disorders of the Nervous System:

Neurodegenerative/ Late Life (eg. Parkinson’s, Alzheimer’s)

Lifespan Development:

Aging

Modeling and Analysis Methods:

Diffusion MRI Modeling and Analysis

Neuroanatomy, Physiology, Metabolism and Neurotransmission:

Subcortical Structures 2

Physiology, Metabolism and Neurotransmission :

Physiology, Metabolism and Neurotransmission Other 1

Keywords:

Basal Ganglia
MRI
Other - obesity; neuroinflammation

1|2Indicates the priority used for review

Provide references using author date format

1. Morys F, Dadar M, Dagher A. Association Between Midlife Obesity and Its Metabolic Consequences, Cerebrovascular Disease, and Cognitive Decline. J Clin Endocrinol Metab. 2021;106:e4260–e4274.
2. Morys F, Yu E, Shishikura M, Paquola C, Vainik U, Nave G, et al. Neuroanatomical correlates of genetic risk for obesity in children. Transl Psychiatry. 2023;13:1.
3. Sewaybricker LE, Huang A, Chandrasekaran S, Melhorn SJ, Schur EA. The significance of hypothalamic inflammation and gliosis for the pathogenesis of obesity in humans. Endocr Rev. 2022. 17 October 2022. https://doi.org/10.1210/endrev/bnac023.
4. Jais A, Brüning JC. Hypothalamic inflammation in obesity and metabolic disease. J Clin Invest. 2017;127:24–32.
5. Szalanczy AM, Key C-CC, Solberg Woods LC. Genetic variation in satiety signaling and hypothalamic inflammation: merging fields for the study of obesity. J Nutr Biochem. 2022;101:108928.
6. Sonnefeld L, Rohmann N, Geisler C, Laudes M. Is human obesity an inflammatory disease of the hypothalamus? Eur J Endocrinol. 2023;188:R37–R45.
7. Miller KL, Alfaro-Almagro F, Bangerter NK, Thomas DL, Yacoub E, Xu J, et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci. 2016;19:1523–1536.
8. Van Essen DC, Ugurbil K, Auerbach E, Barch D, Behrens TEJ, Bucholz R, et al. The Human Connectome Project: a data acquisition perspective. Neuroimage. 2012;62:2222–2231.
9. Theaud G, Houde J-C, Boré A, Rheault F, Morency F, Descoteaux M. TractoFlow: A robust, efficient and reproducible diffusion MRI pipeline leveraging Nextflow & Singularity. Neuroimage. 2020;218:116889.